|
|
Volumn 66, Issue 3, 2002, Pages 141-
|
|
Editorial: Peptides as cancer therapeutics
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIMITOTIC AGENT;
ANTINEOPLASTIC AGENT;
CANCER VACCINE;
CELOGENTIN;
CEMADOTIN;
CRIAMIDE;
CRYTOPHYSIN;
CYTOKINE;
CYTOTOXIC AGENT;
DOLASTATIN;
GONADORELIN DERIVATIVE;
HEMIASTERLIN;
INTERFERON;
INTERLEUKIN 2;
MONOCLONAL ANTIBODY;
MOROIDIN;
PEPTIDE DERIVATIVE;
PEPTIDE LIBRARY;
PEPTIDE VACCINE;
PHOMOPSIN A;
PROTEIN DERIVATIVE;
RECEPTOR SUBTYPE;
SOMATOSTATIN DERIVATIVE;
SOMATOSTATIN RECEPTOR;
TUBULYSIN;
TUMOR VACCINE;
UNCLASSIFIED DRUG;
USTILOXIN;
VITILEVUAMIDE;
CANCER THERAPY;
DRUG EFFECT;
DRUG MECHANISM;
EDITORIAL;
HUMAN;
PHAGE DISPLAY;
PROSTATE CANCER;
PROTEIN TARGETING;
SIDE EFFECT;
|
|
EID: 0036409418
PISSN: 00063525
EISSN: None
Source Type: Journal
DOI: 10.1002/bip.10275 Document Type: Editorial |
|
Times cited : (1)
|
|
References (0)
|